Furthermore, compared to HFD-fed WT mice, HFD-fed MC4RKO mice showed more severe hepatic steatosis and TG content increase and milder recovery of these parameters after peripheral neural blockade and treatment with the HTR2A antagonist. This evidence concerns the gene HTR2A and Hepatic steatosis.